CTT Pharma Uplists to the OTCQB Today
CTT Pharmaceutical Holdings (OTCQB:CTTH) has successfully uplisted to the OTCQB Market effective March 9, 2025, trading under the ticker symbol 'CTTH'.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CTT Pharmaceutical Holdings (OTCQB:CTTH) has successfully uplisted to the OTCQB Market effective March 9, 2025, trading under the ticker symbol 'CTTH'. The company's CEO is scheduled to release a shareholder update on Wednesday, March 12, 2025.
Positive
- Uplisting to OTCQB Market potentially increases visibility and liquidity for shareholders
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TAMPA, FL / ACCESS Newswire / March 9, 2025 / CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has entered the OTCQB Market today under the ticker symbol "CTTH". CTT Pharma's CEO will issue a news release to shareholders this Wednesday March 12, 2025.
About CTT Pharmaceuticals Holdings, Inc.
CTT has patented technology in the United States, Europe, Canada and many additional countries to allow many actives on a dissolvable strip that include but are not limited to Nicotine, Vitamins, and Pharmaceuticals. CTT believes that there is a need for our technology in many industries, which includes a smoke-free nicotine strip that can be used as a smoking cessation product and delivering drugs that can help with pain management and anxiety. CTT Pharma incorporates micelle technology into its drug delivery. These strips dissolve quickly, deliver low dose options and offer better bioavailability.
CTT Pharma - 813-606-0060
SOURCE: CTT Pharmaceutical Holdings, Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.